Flagship Pioneering and Pfizer Announce Strategic Collaboration to Accelerate Innovative Drug Development

Flagship Pioneering and Pfizer Announce Collaboration to Create New Innovative Drug PipelineOn July 18, Flagship Pioneering, a U.S.-based life sciences venture capital firm, and Pfizer announced that the two companies have partnered to create a new innovative drug pipeline. Under the terms of the new agreement, Flagship and Pfizer will each initially invest $50 million, leveraging Flagship's ecosystem of over 40 human health companies and multiple biotechnology platforms to explore opportunities for developing 10 single-asset projects.